ASSET | DATE | % RETURN |
---|---|---|
Vigil Neuroscience (VIGL) | 7/1/2022 - 10/30/2022 | 537.05% |
Enliven Therapeutics (ELVN) | 7/1/2022 - 10/30/2022 | 258.82% |
Astria Therapeutics (ATXS) | 7/1/2022 - 10/30/2022 | 207.53% |
Aehr Test Systems (AEHR) | 7/1/2022 - 10/30/2022 | 196.07% |
89bio (ETNB) | 7/1/2022 - 10/30/2022 | 191.22% |
Terns Pharmaceuticals (TERN) | 7/1/2022 - 10/30/2022 | 176.83% |
Verve Therapeutics (VERV) | 7/1/2022 - 10/30/2022 | 165.84% |
SS Innovations International Inc Common Stock (SSII) | 7/1/2022 - 10/30/2022 | 161.29% |
Avadel Pharmaceuticals (AVDL) | 7/1/2022 - 10/30/2022 | 156.73% |
Biohaven Pharmaceutical (BHVN) | 7/1/2022 - 10/30/2022 | 155.5% |
Ardelyx (ARDX) | 7/1/2022 - 10/30/2022 | 150% |
Sigma Lithium Resources (SGML) | 7/1/2022 - 10/30/2022 | 140.61% |
Prothena (PRTA) | 7/1/2022 - 10/30/2022 | 128.24% |
Bel Fuse B (BELFB) | 7/1/2022 - 10/30/2022 | 122.06% |
Target Hospitality (TH) | 7/1/2022 - 10/30/2022 | 110.84% |
Torm PLC Class A (TRMD) | 7/1/2022 - 10/30/2022 | 105.84% |
Helix Energy Solutions (HLX) | 7/1/2022 - 10/30/2022 | 105.7% |
Clearfield (CLFD) | 7/1/2022 - 10/30/2022 | 98.45% |
CECO Environmental (CECO) | 7/1/2022 - 10/30/2022 | 96.67% |
Pacific Biosciences of California (PACB) | 7/1/2022 - 10/30/2022 | 95.08% |
Amylyx Pharmaceuticals (AMLX) | 7/1/2022 - 10/30/2022 | 92.89% |
Cooper Stnd (CPS) | 7/1/2022 - 10/30/2022 | 90.67% |
Tsakos Energy Navigation (TEN) | 7/1/2022 - 10/30/2022 | 90.36% |
Weave Communications (WEAV) | 7/1/2022 - 10/30/2022 | 85.48% |
Ardmore Shpng (ASC) | 7/1/2022 - 10/30/2022 | 85% |